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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S161Purpose: CCAAT/enhancer-binding protein (C/EBP) is a member of the
leucine zipper family of transcription factors. Among six isoforms of C/
EBP family members, C/EBPa, C/EBPb, C/EBPd and C/EBPε have a
transactivation domain and exert redundant functions in many phys-
iological processes such as cell differentiation, cell proliferation, cell
cycle regulation, inﬂammation and immunity. We previously reported
that C/EBPb is abundantly expressed in chondrocytes and regulates
skeletal growth and osteoarthritis through the induction of cell cycle-
related genes and metalloproteinases. Since the roles of C/EBPa, C/EBPd
and C/EBPε remain unclear, the present study examined expressions
and functions of these C/EBPs in chondrocytes.
Methods: We examined expression levels of the four C/EBPs with
transactivation domains in mouse primary costal chondrocytes by real-
time RT-PCR, and their expression patterns in mouse embryonic limb
cartilage by immunohistochemistry. Transcriptional regulation of rep-
resentative marker gene promoters was assessed by luciferase assay
using HeLa cells transfected with a reporter construct and the expres-
sion vector of each C/EBP. For gain-of-function analyses, each C/EBP was
introduced into mouse chondrogenic cell line ATDC5 by retroviral
vector. For loss-of-function analyses, we prepared A-C/EBP, a designed
dominant-negative construct that can heterodimerize with all C/EBPs
and abolish their DNA binding abilities. We conﬁrmed the protein-
protein binding with A-C/EBP and C/EBPs by mammalian two-hybrid
assay and co-immunoprecipitation assay, and the dominant-negative
effect of A-C/EBP by co-transfectionwith C/EBPs in luciferase assay. A-C/
EBP was introduced into ATDC5 cells by lentiviral vector. To further
investigate entire functions of the C/EBP family, we performed cDNA
microarray analyses using the RNA samples of A-C/EBP or GFP over-
expressing cells. Genes upregulated or downregulated more than twice
by A-C/EBP overexpression were identiﬁed using Genespring software.
Results: Among the four C/EBPs with the transactivation domains,
expression of C/EBPb and C/EBPd in mouse primary costal chondrocytes
was abundant compared to C/EBPa, while C/EBPεwashardly expressed. In
mouse embryonic limb cartilage, C/EBPb and C/EBPd proteins were pre-
dominantly localized in the prehypertrophic and hypertrophic zones,
while C/EBPa protein was localized in the proliferative zone. All three C/
EBPs stimulated promoter activities of matrix metalloproteinase-13
(MMP13) and vascular endothelial growth factor A (VEGFA) genes. Ret-
roviral overexpression of each of the three C/EBPs in ATDC5 cells sup-
pressed expressions of early differentiationmarkers including Col2a1 and
Sox9, and enhanced those of late differentiation markers including
Mmp13andVegfa. Thepresent data imply thatC/EBPb, C/EBPd andC/EBPa
have redundant function in chondrocytes and may compensate each
other. To investigate loss-of-functionof the threeC/EBPs,weusedA-C/EBP
which exerts a dominant-negative effect against all C/EBPs. We ﬁrst
conﬁrmed that A-C/EBP could bind with all three C/EBPs by mammalian
two-hybrid assay and co-immunoprecipitation assay. The A-C/EBP
transfection reduced the enhancement of MMP13 and VEGFA promoter
activities by the three C/EBPs in a dose-dependent manner. When we
introduced A-C/EBP into ATDC5 cells by lentiviral vector, expressions of
Col2a1 and Sox9 were increased, and those of Mmp13 and Vegfa were
decreased, conﬁrming that these three C/EBPs suppress the early stage of
chondrocyte differentiation while enhancing the late stage. Finally, gen-
eontology analyses based on the cDNA microarray data identiﬁed many
genes regulated by the A-C/EBP overexpression: 19, 17, 35 and 13 genes
were upregulated while 26, 41, 97 and 62 genes were downregulated in
the skeletal development-related, cell cycle-related, apoptosis-related,
and inﬂammation-related gene groups, respectively.
Conclusions: C/EBPb, C/EBPd and C/EBPa were expressed in chon-
drocytes, and regulate proliferation and differentiation of chondrocytes.
The loss-of-function analyses by A-C/EBP also suggests the involvement
of the C/EBPs in apoptosis and inﬂammation. These results suggest that
C/EBPs may play a variety of roles in the homeostasis of joint cartilage
under physiological and pathological conditions.
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and Adolescent Med., Univ. of Freiburg, Freiburg, GermanyPurpose: The ribonuclease mitochondrial RNA processing (RMRP)
gene encodes the non-coding RNA component of a multi-protein-
RNA complex called RNase MRP. This small nucleolar ribonucleo-
protein particle is implicated in various cellular processes, including
ribosomal biogenesis, mitochondrial RNA cleavage, cell cycle regu-
lation and has been linked to telomerase. Mutations in the RMRP
gene cause Cartilage Hair Hypoplasia (CHH). The main phenotypic
hallmark of CHH is dwarﬁsm. In agreement with a pivotal role in
determining chondrogenic cell fate, we have previously found that
RMRP expression is predominantly associated with chondrocyte
hypertrophy and that RNAi-mediated knockdown (KD) of RMRP RNA
leads to deregulation of the chondrogenic differentiation program of
ATDC5 cells. Importantly, we could also conﬁrm that chondrogenic
transdifferentiation of CHH patient-derived ﬁbroblasts was impaired.
Our most recent ﬁndings indicate that bone morphogenic protein 2
(BMP-2) signaling may be involved in regulating transcription of the
RMRP gene, thereby connecting RMRP expression to important
chondrogenic signaling networks. As BMP-2 is known to activate
NFlB/p65 and chondrocyte hypertrophy is associated with similar
cell stress-signaling, we hypothesized that NFlB/p65 acts as a tran-
scriptional activator of RMRP gene expression during chondrogenic
differentiation.
Methods: RMRP, p65 or Bapx1/Nkx3.2 expression was targeted in
ATDC5 or SW1353 cells by transfection of custom-made speciﬁc
siRNA duplexes. Gene expression was analyzed by RT-qPCR. In silico
analyses of the murine and human RMRP promoter was performed
on the -600 bp proximal promoters using MatInspector from
Genomatix. SW1353 cells (either mock transfected or Bapx1/Nkx3.2
KD) were exposed to human IL-1b (10 ng/ml) or human TNF-a (20
ng/ml) for 2 days.
Results: To investigate how RMRP is implicated in chondrogenic
differentiation, we genetically targeted RMRP expression using RNAi
in ATDC5 cells. KD of RMRP expression caused deregulation of
chondrogenic differentiation, characterized by signiﬁcantly reduced
expression of Sox9, Col2a1, Runx2 and Col10a1 mRNAs. Interestingly,
KD of RMRP expression resulted in signiﬁcantly increased expression
of the hypertrophic repressor Bapx1/Nkx3.2, suggesting a potential
role for RMRP in determining the hypertrophic differentiation fate.
Conﬁrming a close connection with hypertrophic differentiation,
BMP-2 (not BMP-7) was speciﬁcally able to increase the expression
of RMRP in ATDC5 cells. BMP-2 is known to activate NFlB/p65 and
chondrocyte hypertrophy is associated with similar cell stress-sig-
naling. Therefore we further investigated the relation between RMRP,
p65 and hypertrophic differentiation. To determine whether NFlB/
p65 may be involved in transcription of RMRP, the expression of p65
mRNA was targeted by transfection of speciﬁc siRNA duplexes. KD of
p65 mRNA expression indeed resulted in signiﬁcant downregulation
of RMRP expression in ATDC5 cells. In silico analyses for the pres-
ence of transcription factor binding sites in the murine and human
RMRP proximal promoters predicted the conserved presence of
putative NFlB binding sites. Complementary to above p65 RNAi, we
exposed SW1353 chondrosarcoma cells to NFlB/p65 activating
cytokines IL1b or TNFa and determined whether RMRP expression
responded to NFlB/p65 activation. The expression of RMRP did not
respond signiﬁcantly to exposure to IL1b or TNFa. Subsequently, to
force cells into hypertrophic signaling, we interfered with Bapx1/
Nkx3.2 expression by RNAi. Indeed cells acquired an increased
hypertrophic phenotype, but RMRP expression was not affected.
Surprisingly, when Nkx3.2/Bapx1 KD cells were exposed to similar
IL1b or TNFa conditions, the expression of RMRP increased
drastically.
Conclusions: These data show that RMRP expression levels determine
chondrogenic differentiation fate and suggest that RMRP expression
may depend on NFlB/p65. However, activation of NFlB/p65 by IL1b or
TNFa alone was found not to be sufﬁcient for induction of RMRP
expression. In contrast, forced hypertrophic differentiation by Bapx1/
Nkx3.2 KD in the presence of IL1b or TNFa was speciﬁcally able to
increase RMRP expression, which is in agreement with the BMP-2-
induced RMRP expression. We thus conclude that RMRP exerts crucial
regulatory functions required for chondrogenic differentiation and our
current efforts are focused on elucidating which function of RNase MRP
is predominantly involved in chondrogenic differentiation, as well as
further establishing NFlB/p65 as a transcription factor for RMRP gene
expression.
